Once feasibility has been established, activities can accelerate to include shift to more production-level manufacturing processes, definition of product sterilization, assembly, and packaging, and pre-validation of analytical methods. Preliminary product specifications are established, and draft batch records prepared for use in GLP preclinical product and tox builds. Informal stability testing may be considered to establish suitable future storage conditions and preliminary shelf-life.
